Previous 10 | Next 10 |
2024-04-04 08:45:00 ET Artificial intelligence (AI) will revolutionize the way many companies do business. It could even fundamentally change entire industries. Picking the corporations driving these changes could pay off massive dividends -- literally and figuratively -- down the road. ...
SALT LAKE CITY, March 26, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced the release of its third annual Environmental, Social and Governance (ESG) Report . The repo...
2024-03-21 12:34:51 ET Summary Nvidia Corporation strategically invests in key sectors of the AI space to enhance its future capabilities and bottom line. Investments in Databricks, ARM Inc., Recursion Pharmaceuticals, and SoundHound AI have the potential to boost Nvidia's earning...
2024-03-21 11:53:17 ET More on S&P 500 Index: Chairman Powell Hits A Grand Slam Home Run Despite What The Fed Says, The Policy Is Still 'Higher-For-Longer' The Fed Is More Dovish Than The Market Anticipates 32 “Breakthroughs” stocks by BofA ...
2024-03-19 20:50:22 ET Summary Recursion Pharmaceuticals has seen a 35% increase in stock price, driven by investments from NVIDIA and Roche. Key pipeline projects target unmet needs in CCM, NF2, and Familial Adenomatous Polyposis, with significant R&D investment reported. ...
2024-03-15 10:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-13 17:07:28 ET Gainers: Turtle Beach ( HEAR ) +22% . SoundHound ( SOUN ) +12% . Robinhood Markets ( HOOD ) +9% . Recursion Pharmaceuticals ( RXRX ) +7% . Pyxis Oncology ( PYXS ) +3% . Losers: WW International ( ...
2024-03-12 15:08:43 ET More on S&P 500 Index: The Great Paradox Of The U.S. Market Stocks Rally As Implied Volatility Drops Following Hot CPI Report February CPI: Back-To-Back Hot Inflation May Extend The Fed's Pause Nasdaq, S&P, Dow climb as latest C...
LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced plans to open a new office in London’s vibrant King’s Cross neighborhood. Set to formally open in June ...
2024-03-07 10:28:00 ET On Monday, Keybanc analyst Scott Schoenhaus revised his price target on Recursion Pharmaceuticals (NASDAQ: RXRX) upward, opining the stock would climb by 33% and hit $16. The call came days after the rare-disease drug developer reported 2023 fourth-quarter ear...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
2024-05-15 08:45:00 ET As you may have heard, there's a new trend in biotech lingo wherein companies call themselves "TechBio" rather than "biotech" to emphasize their forward-thinking about the role of information technology. Biotechs like Ginkgo Bioworks (NYSE: DNA) , Recursion ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) made waves Monday with the announcement of the completion of its groundbreaking BioHive-2 supercomput...
Shares of Akoustis Technologies, Inc. (NASDAQ:AKTS) fell sharply in today's session following weak quarterly results. Akoustis Technologies po...